We explore how and to what extent prescription drug insurance expansions affect incentives for pharmaceutical … advertising. When insurance expansions make markets more profitable, firms respond by boosting advertising. Theory suggests this … subsidized prescription drug insurance on the utilization and welfare of consumers outside the program. …

Recent research has documented a link between consumer risk preferences over health and the willingness to pay (WTP …) for medical technologies. However, the absence of empirical health risk preference estimates so far limits the … individual risk preference parameters over health-related quality of life (HRQoL) that shed light on health risk attitudes and …

By influencing the size and bargaining power of private insurers, public subsidization of private health insurance may …-alone drug insurance. © 2015 The President and Fellows of Harvard College and the Massachusetts Institute of Technology …

) Promoting efficiency in the health insurance market can reduce static losses in the goods market while improving the dynamic … even absent. Health insurance, frequently implemented as an ex ante premium coupled with an ex post co-payment per unit … inefficiently constraining quantity. This view of health insurance contracts has several implications: (1) Low ex post copayments to …

. Public prescription drug insurance escapes that trade-off and achieves an elusive goal: lowering static deadweight loss … drug insurance can be welfare-improving, even for risk-neutral and purely self-interested consumers. In spite of its … publicly financing the benefit. The analysis of static and dynamic efficiency also has implications for policies complementary …

Public financing of private health insurance may generate external effects beyond the subsidized population, by … influencing the size and bargaining power of health insurers. We test for this external effect in the context of Medicare Part D …